Table 1 Characteristics of pathology reports.
Internal series | External series | |||
|---|---|---|---|---|
N | (%) | N | (%) | |
239 | (100.0) | 93 | (100.0) | |
Diagnosis | ||||
DLBCL | 106 | (44.4) | 49 | (52.7) |
FCL | 79 | (33.1) | 24 | (25.8) |
MCL | 54 | (22.6) | 20 | (21.5) |
Specimen type | ||||
LN | 110 | (46.0) | 53 | (57.0) |
EN | 76 | (31.8) | 28 | (30.1) |
BM | 39 | (16.3) | 12 | (12.9) |
PB | 2 | (0.8) | 0 | (0.0) |
NA | 12 | (5.0) | 0 | (0.0) |
Bone biopsy | ||||
Yes | 37 | (15.5) | 14 | (15.1) |
No | 202 | (84.5) | 79 | (84.9) |
IHC Execution | ||||
Yes | 227 | (95.0) | 93 | (100.0) |
No | 12 | (5.0) | 0 | (0.0) |
IHC Markers | ||||
MYC | ||||
Positive | 19 | (7.9) | 30 | (32.3) |
Negative | 16 | (6.7) | 8 | (8.6) |
NA | 204 | (85.4) | 55 | (59.1) |
BCL2 | ||||
Positive | 139 | (58.2) | 72 | (77.4) |
Negative | 43 | (18.0) | 6 | (6.5) |
NA | 57 | (23.8) | 15 | (16.1) |
BCL6 | ||||
Positive | 136 | (56.9) | 59 | (63.4) |
Negative | 51 | (21.3) | 11 | (11.8) |
NA | 52 | (21.8) | 23 | (24.7) |
CD10 | ||||
Positive | 87 | (3.6) | 40 | (4.3) |
Negative | 83 | (34.7) | 39 | (41.9) |
NA | 69 | (28.9) | 14 | (15.1) |
CD20 | ||||
Positive | 215 | (90.0) | 84 | (90.3) |
Negative | 0 | (0.0) | 2 | (2.2) |
NA | 24 | (10.0) | 7 | (7.5) |
Cyclin D1 | ||||
Positive | 47 | (19.7) | 21 | (22.6) |
Negative | 34 | (14.2) | 22 | (23.7) |
NA | 158 | (66.1) | 50 | (53.8) |
FISH | ||||
Yes | 69 | (28.9) | 5 | (5.4) |
No | 170 | (71.1) | 88 | (94.6) |
Cell of origin | ||||
GCB | 9 | (3.8) | 14 | (15.1) |
Not GCB | 34 | (14.2) | 19 | (20.4) |
NA | 196 | (82.0) | 60 | (64.5) |
Ki-67 | ||||
< 30 | 54 | (22.6) | 17 | (18.3) |
≥ 30 | 132 | (55.2) | 58 | (62.4) |
NA | 53 | (22.2) | 18 | (19.4) |
